Form 4: Aspen Aerogels SVP Landes Reports Equity Grants

Aspen Aerogels' SVP of Operations and Strategic Development, Gregg Landes, reported the acquisition of restricted stock units and stock options, alongside a tax-related disposition.

Summary

• Gregg Landes, SVP, Operations and Strategic Development at Aspen Aerogels Inc. (ASPN), reported transactions involving the company's common stock and derivative securities.
• On March 4, 2026, Landes acquired 57,462 Restricted Stock Units (RSUs) at a price of $0, representing the right to receive one share of Common Stock per RSU upon vesting.
• These RSUs vest in three equal annual installments: one-third on March 4, 2027, one-third on March 4, 2028, and the final one-third on March 4, 2029.
• Following this acquisition, Landes beneficially owned 108,669 non-derivative securities.
• Also on March 4, 2026, Landes acquired 77,824 stock options with an exercise price of $3.35 per share, expiring on March 4, 2036.
• These stock options also vest in three equal annual installments: one-third on March 4, 2027, one-third on March 4, 2028, and the final one-third on March 4, 2029.
• On March 5, 2026, 3,814 shares of Common Stock were disposed of at a price of $3.27 per share to satisfy minimum statutory tax withholding requirements related to the vesting of RSUs.
• After all reported transactions, Landes beneficially owns 104,855 non-derivative securities, consisting of 22,735 shares of Common Stock and 82,120 RSUs, in addition to 77,824 stock options.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing as moderately positive, reflecting routine executive compensation that aligns management incentives with shareholder value creation, without indicating any immediate operational or financial shifts.

Positives

• The acquisition of 57,462 Restricted Stock Units (RSUs) and 77,824 stock options aligns management's long-term interests with those of shareholders, incentivizing performance and retention.
• The grants demonstrate continued confidence in the company's future by a key executive.

Future Outlook

The vesting schedules for the Restricted Stock Units and stock options extend through March 4, 2029, indicating a long-term incentive structure for the Senior Vice President of Operations and Strategic Development.

Industry Context

StockSavvy.ai notes that equity grants, such as Restricted Stock Units and stock options, are standard components of executive compensation packages across various industries. These grants are designed to align the interests of executives with those of shareholders by tying a significant portion of their compensation to the company's stock performance over a multi-year period. The vesting schedule reported is typical for such long-term incentive plans.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) and stock options for executive compensation is a common practice, comparable to incentive structures seen at companies like Tesla, which frequently uses stock-based compensation to motivate executives towards long-term growth targets.
• The three-year annual vesting schedule for both RSUs and options is a standard approach, similar to what is observed in many technology and manufacturing firms, ensuring executive retention and sustained focus on company performance over several fiscal periods.
• The tax withholding upon RSU vesting is a routine event, consistent with compensation practices across publicly traded companies, including peers in the advanced materials sector.

Stakeholder Impact

• Shareholders: The equity grants align the interests of a key executive with shareholders, potentially fostering long-term value creation.
• Employees: Standard executive compensation practices can influence overall company morale and compensation strategies.

Next Steps

• The vesting of Restricted Stock Units and stock options will occur in three annual installments on March 4, 2027, March 4, 2028, and March 4, 2029.

Key Dates

Keywords

Aspen Aerogels, ASPN, Form 4, Insider Transaction, Restricted Stock Units, Stock Options, Executive Compensation, Equity Grant, Vesting Schedule